Beginning in late July, NIH will start introducing a new website experience designed to make it easier to find health information, research, funding opportunities, and other resources. During the transition, you may notice changes to navigation, page layouts, and where some information is located.
Crina, a bio-organic chemist, manages Centers of Biomedical Excellence (COBRE) and Support for Research Excellence (SuRE) grants and oversees the COBRE Phase 3 initiative.
UPDATE: The video for this webinar is now available.
We’re pleased to announce that the Centers of Biomedical Research Excellence (COBRE) Phase 3 notice of funding opportunity (NOFO) (PAR-23-216) has been reissued. The COBRE program supports the establishment and development of innovative biomedical and behavioral research centers at Institutional Development Award (IDeA)-eligible institutions. The goal of this NOFO is to solidify the research base built in Phases 1 and 2 through continued support of research and research infrastructure and to implement strategies to sustain research excellence beyond COBRE funding.
Application due date: September 26, 2023 Earliest start date: July 2024
We’re pleased to announce that we’ve published two notices of special interest (NOSI) calling for applications to PAR-19-313, Centers of Biomedical Research Excellence (COBRE) Phase 1 (P20 Clinical Trial Optional), that focus on research on women’s health (NOT-GM-21-056) and data sciences (NOT-GM-21-062).
These NOSIs highlight the Office of Research on Women's Health's interest in supporting a meritorious application on women's health, and the Office of Data Science Strategy’s interest in supporting a meritorious application on data science relevant to biomedical research. Applications for these NOSIs must be submitted in response to and meet all eligibility criteria of PAR-19-313.
National Institute of
